BRD4 and astrocytoma (excluding glioblastoma): Overall, these data suggest that increased BRD4 activity results in enhanced malignancy only in IDHmut glioma, particularly astrocytomas, whereas increased BRD3 activity results in enhanced survival only in IDHwt glioma.